The Dow Jones Industrial Average fell on Tuesday as the Federal Reserve kicked off a two-day monetary policy meeting.US Marketsread more
Brent crude oil jumped the most in history in the previous session after attacks on Saudi's oil industry disrupted the kingdom's production.Marketsread more
Facebook has partnered with Ray-Ban maker Luxottica to develop augmented-reality glasses, people familiar with the matter told CNBC. The glasses, code-named 'Orion,' are being...Technologyread more
The fallout from two fatal crashes of Boeing 737 Max planes has ensnared the manufacturer's most-loyal customer: Southwest Airlines. The carrier has canceled thousands of...Airlinesread more
Pelosi also said it's "irrelevant" whether approving the USMCA trade deal would give President Donald Trump a victory ahead of the 2020 election.Politicsread more
The fine against Carmene "Zsa Zsa" DePaolo was the maximum possible civil penalty that she faced under the Hatch Act for her comments about Hillary Clinton's immigration plan...Politicsread more
Sen. Elizabeth Warren has called on lobbyists to be banned from donating and fundraising for their preferred campaigns. Her new plan represents the latest shift for Warren who...2020 Electionsread more
Fifty percent of Saudi Arabia's crude production taken offline from Saturday's attack has been restored in the past two days, the kingdom's energy minister told reporters...Oilread more
General Motors stands to lose hundreds of millions of dollars in lost production as a United Auto Workers union strike against the automaker enters its second day, but Wall...Autosread more
The White House and GM denied a report in Politico that said the Trump administration was involved in the automaker's contract negotiations with the United Auto Workers union.Autosread more
WeWork hopes to sharpen its story for investors as it works to get its on-again, off-again IPO back on track.Technologyread more
Alphabet's Verily division has hired former FDA chief Dr. Robert Califf as an adviser, the company announced in a blog post Wednesday.
CNBC on Tuesday exclusively reported that the company was talking to Califf.
Califf will help oversee Project Baseline, a well-funded effort headed by fellow cardiologist Dr. Jessica Mega to study human health by tracking 10,000 people over at least four years. He will also continue to work at the Duke University Clinical Research Institute and have a new appointment as an adjunct professor in the Department of Medicine at Stanford. Duke and Stanford are teaming up with Verily for the baseline study.
The appointment of Califf is a big win for Verily, and couldn't come at a better time. The company just lost its top academic, former National Institute of Mental Health chief, Dr. Tom Insel.
Califf was nominated for the FDA role by President Barack Obama and stepped down in January, a standard procedure with a new administration. Shortly after stepping down, he spoke out in an interview about the antiquated ways in which companies collect medical data to test drugs and medical devices. He suggested that clinical trials should look more like A/B comparison tests routinely done by tech companies, such as Google.
It's not typical for health agency chiefs to join technology companies, but it might increasingly be an option as Silicon Valley starts moving into regulated industries. Verily works closely with life sciences companies including Dexcom, Sanofi and Johnson & Johnson on health hardware and software projects.